Cardiomyopathy Trial, Recruiting NCT06620705 Sponsor: srdpiers Condition: Cardiomyopathy
Back to Cardiomyopathy

Cardiomyopathy Trial, Recruiting

NCT06620705
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older and have a permanent irregular heart rhythm (called atrial fibrillation) along with a heart that pumps less efficiently than normal (less than 50% of its capacity)
  • You either need electrical pacing to keep your heart from beating too slowly (including if you are having a procedure to block the heart's electrical connection), or your doctor has recommended a special type of pacemaker that helps both sides of the heart work together (called cardiac resynchronization therapy)
  • It is expected that your pacemaker will need to actively pace your heart more than 40% of the time
  • You have been on optimized heart failure medications for at least 3 months
  • You already have a heart device but need it upgraded to a cardiac resynchronization therapy device (you may still be eligible)

Who may not be able to join:

  • You are under 18 years old
  • You are pregnant or are actively trying to become pregnant
  • You are not able to have the required pacemaker leads (wires) implanted in the necessary locations in your heart (confirm with trial site)
  • You have had a heart valve procedure, heart valve surgery, or a heart attack within the last 6 months
  • You have the most severe stage of heart failure (where you are severely limited even at rest), or you currently have a mechanical heart pump implanted, or you have had a heart transplant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sebastiaan Piers, MD, PhD, Leiden University Medical Center, Leiden, the Netherlands

Phone: +31715262020

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
srdpiers
Registry
ClinicalTrials.gov
Start date
10 September 2024
Est. completion
1 September 2027

Where this trial is recruiting

🇩🇰 Denmark 🇳🇱 Netherlands

Primary endpoints

Left ventricular end-systolic volume (LVESV) change

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov